> top > docs > PMC:7340597 > spans > 1965-4087 > annotations

PMC:7340597 / 1965-4087 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T4 290-296 Body_part denotes thorax http://purl.org/sig/ont/fma/fma9576
T5 573-577 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T6 1306-1312 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T7 1458-1466 Body_part denotes alveolar http://purl.org/sig/ont/fma/fma264783
T8 1787-1791 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T9 1792-1798 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T3 573-577 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T4 1306-1312 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T5 1787-1791 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T6 1792-1798 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
119 62-70 Species denotes patients Tax:9606
120 192-200 Species denotes patients Tax:9606
121 478-486 Species denotes patients Tax:9606
122 1034-1042 Species denotes patients Tax:9606
123 1150-1158 Species denotes patients Tax:9606
124 1436-1444 Species denotes patients Tax:9606
125 1808-1816 Species denotes patients Tax:9606
126 26-50 Disease denotes coronavirus disease 2019 MESH:C000657245
127 52-60 Disease denotes COVID-19 MESH:C000657245
128 144-163 Disease denotes respiratory failure MESH:D012131
129 327-362 Disease denotes acute respiratory distress syndrome MESH:D012128
130 364-368 Disease denotes ARDS MESH:D012128
131 469-477 Disease denotes COVID-19 MESH:C000657245
132 559-563 Disease denotes ARDS MESH:D012128
133 894-908 Disease denotes thromboembolic MESH:D013923
134 939-952 Disease denotes aspergillosis MESH:D001228
135 982-1004 Disease denotes venous thromboembolism MESH:D054556
136 1025-1033 Disease denotes COVID-19 MESH:C000657245
137 1077-1100 Disease denotes pulmonary aspergillosis MESH:D055732
138 1141-1149 Disease denotes COVID-19 MESH:C000657245
139 1188-1196 Disease denotes COVID-19 MESH:C000657245
140 1205-1209 Disease denotes ARDS MESH:D012128
141 1270-1274 Disease denotes ARDS MESH:D012128
142 1335-1353 Disease denotes infectious disease MESH:D003141
143 1427-1435 Disease denotes COVID-19 MESH:C000657245
144 1458-1473 Disease denotes alveolar damage MESH:D055370
145 1494-1498 Disease denotes ARDS MESH:D012128
146 1545-1553 Disease denotes COVID-19 MESH:C000657245
147 1565-1588 Disease denotes pulmonary aspergillosis MESH:D055732
148 1665-1674 Disease denotes mortality MESH:D003643
149 1823-1828 Disease denotes COVID MESH:C000657245
150 1837-1841 Disease denotes ARDS MESH:D012128
151 2067-2075 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T35 26-50 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T36 52-60 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T37 144-163 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T38 327-362 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T39 333-362 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T40 364-368 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T41 469-477 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T42 559-563 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T43 939-952 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T44 982-1004 Disease denotes venous thromboembolism http://purl.obolibrary.org/obo/MONDO_0005399
T45 1025-1033 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T46 1087-1100 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T47 1141-1149 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T48 1188-1196 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T49 1205-1209 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T50 1270-1274 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T51 1335-1353 Disease denotes infectious disease http://purl.obolibrary.org/obo/MONDO_0005550
T52 1427-1435 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T53 1494-1498 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T54 1545-1553 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T55 1575-1588 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T56 1590-1594 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T57 1728-1732 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T58 1837-1841 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T59 2067-2075 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T15 177-183 http://purl.obolibrary.org/obo/CLO_0001302 denotes 3], [4
T16 290-296 http://www.ebi.ac.uk/efo/EFO_0000965 denotes thorax
T17 573-577 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T18 573-577 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T19 845-846 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T20 1507-1509 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T21 1787-1791 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T22 1787-1791 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T2 1629-1639 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T7 144-163 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T8 333-353 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T9 894-908 Phenotype denotes thromboembolic http://purl.obolibrary.org/obo/HP_0001907
T10 989-1004 Phenotype denotes thromboembolism http://purl.obolibrary.org/obo/HP_0001907
T11 1450-1473 Phenotype denotes diffuse alveolar damage http://purl.obolibrary.org/obo/HP_0033006

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T24 0-370 Sentence denotes Up to 20% of hospitalized coronavirus disease 2019 (COVID-19) patients are admitted to the intensive care unit (ICU) because of acute hypoxemic respiratory failure. [[1], [2], [3], [4]] These patients usually present with bilateral patchy ground glass opacities on computed tomography (CT) thorax fulfilling the definition for acute respiratory distress syndrome (ARDS).
T25 371-805 Sentence denotes Often an atypical high compliance phenotype (L-type) is observed during mechanical ventilation in COVID-19 patients in contrast to mechanical ventilation characteristics typically seen in ARDS with low lung compliance phenotype (H -type). [5,6] During ICU stay the radiologic presentation of bilateral patchy ground glass opacities as present at admission often progress to consolidations with or without fibrotic characteristics [7].
T26 806-953 Sentence denotes Two earlier observed features may play a critical role in the severity of this disease: thromboembolic complications and early onset aspergillosis.
T27 954-1067 Sentence denotes The cumulative incidence of venous thromboembolism reported was 49% in COVID-19 patients admitted to the ICU [8].
T28 1068-1163 Sentence denotes Presumed pulmonary aspergillosis may be present in as much as 19% of ICU COVID-19 patients [9].
T29 1164-1382 Sentence denotes Since the physiology in COVID-19 related ARDS as well as its complications seems to differ from “typical’ ARDS, an insight into the pulmonary tissue pathology of this new infectious disease is of the utmost importance.
T30 1383-1518 Sentence denotes The scarcely available pathological data in COVID-19 patients show diffuse alveolar damage, closely related to ARDS [[10], [11], [12]].
T31 1519-1754 Sentence denotes The clinical relevance of COVID-19-associated pulmonary aspergillosis (CAPA) as well as survival benefit with antifungal treatment and associated mortality are under debate since histopathological evidence of CAPA is not obtained [13].
T32 1755-1876 Sentence denotes We examined postmortem obtained lung tissue in seven patients, with COVID related ARDS who needed mechanical ventilation.
T33 1877-2000 Sentence denotes The histopathologic findings, together with clinical features, radiological and microbiological findings are reported here.
T34 2001-2122 Sentence denotes This report may contribute to new insights in the pathogeneses of COVID-19 as well as suggestions for treatment strategy.

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T44 1427-1435 SP_7 denotes COVID-19
T27 26-37 NCBITaxon:11118 denotes coronavirus
T28 52-60 SP_7 denotes COVID-19
T29 101-105 UBERON:0007221 denotes care
T30 144-155 UBERON:0001004 denotes respiratory
T31 290-296 UBERON:0000915 denotes thorax
T32 333-344 UBERON:0001004 denotes respiratory
T33 469-477 SP_7 denotes COVID-19
T34 573-577 UBERON:0002048 denotes lung
T35 894-908 GO:0007596 denotes thromboembolic
T36 982-988 UBERON:0001638 denotes venous
T37 989-1004 GO:0007596 denotes thromboembolism
T38 1025-1033 SP_7 denotes COVID-19
T39 1077-1086 UBERON:0002048 denotes pulmonary
T40 1141-1149 SP_7 denotes COVID-19
T41 1188-1196 SP_7 denotes COVID-19
T42 1296-1305 UBERON:0002048 denotes pulmonary
T43 1306-1312 UBERON:0000479 denotes tissue
T45 1458-1466 UBERON:0003215 denotes alveolar
T46 1545-1553 SP_7 denotes COVID-19
T47 1565-1574 UBERON:0002048 denotes pulmonary
T48 1767-1777 GO:0016265 denotes postmortem
T49 1787-1791 UBERON:0002048 denotes lung
T50 1792-1798 UBERON:0000479 denotes tissue
T51 2067-2075 SP_7 denotes COVID-19
T62119 1823-1828 SP_7 denotes COVID
T66936 209-217 SP_7 denotes present
T35906 347-359 SP_7 denotes stress syndr
T89649 360-370 SP_7;UBERON:0001004 denotes me (ARDS).
T80423 371-394 SP_7 denotes Often an atypical high
T77332 396-406 SP_7 denotes mpliance p
T23414 451-461 UBERON:0001004 denotes al ventila
T23002 529-539 GO:0016265 denotes acteristic
T60852 567-571 UBERON:0002048 denotes h lo
T36899 621-631 SP_7 denotes g ICU stay
T82912 662-683 GO:0001171 denotes bilateral patchy gro
T17380 722-728 UBERON:0007311 denotes sion o
T17660 736-743 UBERON:0004242 denotes gress t
T50696 817-826 GO:0007586;UBERON:0001555 denotes observed
T86112 827-832 UBERON:0001555 denotes featu
T42737 856-867 CHEBI:3638;DG_10;CHEBI:3638 denotes role in the
T83979 1002-1017 GO:0050817 denotes sm reported was
T7331 1044-1051 CHEBI:24505;CHEBI:24505 denotes dmitted
T34114 1149-1158 UBERON:0002048 denotes patients
T52553 1234-1243 UBERON:0002048 denotes ions seem
T21703 1336-1349 CHEBI:27680;CHEBI:27680 denotes nfectious dis
T97231 1351-1356 UBERON:0001977 denotes se is
T41661 1361-1367 UBERON:0007311 denotes he utm
T93902 1370-1378 UBERON:0003126 denotes importa
T75668 1382-1389 UBERON:0004242 denotes The sc
T99671 1403-1416 CHEBI:27680;CHEBI:27680 denotes le pathologic
T86981 1435-1450 UBERON:0002031 denotes patients show
T51837 1451-1457 UBERON:0004821 denotes iffuse
T19506 1491-1498 CHEBI:59132;CHEBI:59132 denotes to ARDS
T9649 1577-1586 UBERON:0002048 denotes pergillos
T41715 1808-1813 UBERON:0001977 denotes patie
T81615 1818-1829 NCBITaxon:5052 denotes with COVID
T80302 1858-1868 GO:0016265 denotes nical vent
T65199 1895-1899 UBERON:0002048 denotes c fi
T43236 1945-1955 GO:0016265 denotes logical an
T69714 1998-2003 UBERON:0000170 denotes e. Th
T56052 2025-2030 GO:0016265 denotes te to
T98173 2032-2036 UBERON:0002048 denotes ew i
T61880 2100-2108 UBERON:0001062 denotes or treat

2_test

Id Subject Object Predicate Lexical cue
32674001-32109013-58631465 167-168 32109013 denotes 1
32674001-32320003-58631466 177-178 32320003 denotes 3
32674001-32091533-58631467 182-183 32091533 denotes 4
32674001-32228035-58631468 611-612 32228035 denotes 5
32674001-32105637-58631469 802-803 32105637 denotes 7
32674001-32381264-58631470 1064-1065 32381264 denotes 8